These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 76484)

  • 41. Anomalous H-2 antigens on tumour cells.
    Lindahl KF
    Nature; 1979 Jul; 280(5718):105-6. PubMed ID: 95349
    [No Abstract]   [Full Text] [Related]  

  • 42. The structure and function of histocompatibility antigens.
    Cunningham BA
    Sci Am; 1977 Oct; 237(4):96-107. PubMed ID: 410101
    [No Abstract]   [Full Text] [Related]  

  • 43. H-2 antigens incorporated into phospholipid vesicles interact specifically with allogeneic cytotoxic T lymphocytes.
    Hale AH; Evans DL; McGee MP
    Cell Immunol; 1981 Sep; 63(1):42-56. PubMed ID: 6974048
    [No Abstract]   [Full Text] [Related]  

  • 44. The in vivo coating of tumor cells by potentially cytotoxic antitumor antibodies.
    Ran M; Witz IP; Klein G
    Adv Exp Med Biol; 1976; 66():451-6. PubMed ID: 57705
    [No Abstract]   [Full Text] [Related]  

  • 45. Ultrastructural studies of C1300 neuroblastoma cell interaction with syngeneic spleen lymphoid cells.
    Procicchiani G; Fiorani M; Revoltella R
    Cell Immunol; 1979 Apr; 44(1):39-50. PubMed ID: 455475
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunogenetic and immunochemical studies of H-2 antigens of foreign haplotypes on tumour cells.
    Festenstein H; Schmidt W; Testorelli C; De Giorgi L; Morelli O; Matossian-Rogers A; Atfield G
    J Immunogenet; 1979 Aug; 6(4):263-70. PubMed ID: 93131
    [No Abstract]   [Full Text] [Related]  

  • 47. Surface analysis of early and late MOPC-3 15-EL tumor cells.
    Harris D; Bailey J; Lewis JC; Grover WH; Panetti M; Evans DL; Ruebush MJ; Paulus LK; Burgess D; Hale AH
    Cell Immunol; 1981 Oct; 64(1):119-30. PubMed ID: 7296672
    [No Abstract]   [Full Text] [Related]  

  • 48. H-2 antigens on a murine lymphoma are associated with additional proteins.
    Callahan GN; Allison JP
    Nature; 1978 Jan; 271(5641):165-7. PubMed ID: 74802
    [No Abstract]   [Full Text] [Related]  

  • 49. On the nature of F9 antigenic determinants.
    Buc-Caron MH; Dupouey P
    Mol Immunol; 1980 May; 17(5):655-64. PubMed ID: 6163961
    [No Abstract]   [Full Text] [Related]  

  • 50. The plasma membrane 'skeleton' of tumor and lymphoid cells: a role in cell lysis?
    Mescher MF; Apgar JR
    Adv Exp Med Biol; 1985; 184():387-400. PubMed ID: 3898756
    [No Abstract]   [Full Text] [Related]  

  • 51. Cell membrane associated antigens in chemical carcinogenesis.
    Baldwin RW; Price MR
    Biomembranes; 1976; 8():89-129. PubMed ID: 786392
    [No Abstract]   [Full Text] [Related]  

  • 52. Oncornavirus genes and host proteins.
    Del Villano BC; Nave B; Lerner RA
    Bibl Haematol; 1975 Oct; (43):110-4. PubMed ID: 60995
    [No Abstract]   [Full Text] [Related]  

  • 53. Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation.
    Carraway KL; Fregien N; Carraway KL; Carraway CA
    J Cell Sci; 1992 Oct; 103 ( Pt 2)():299-307. PubMed ID: 1478934
    [No Abstract]   [Full Text] [Related]  

  • 54. Virion and tumor cell antigens of C-type rna tumor viruses.
    Bauer H
    Adv Cancer Res; 1974; 20():275-341. PubMed ID: 4376332
    [No Abstract]   [Full Text] [Related]  

  • 55. Specific cell-induced transformation of Paramecium surface antigens.
    Finger I; Heller C; von Allmen C
    Differentiation; 1978 Jul; 11(1):51-7. PubMed ID: 79514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Receptors, cell membranes and cancer].
    S Afr Med J; 1976 Nov; 50(50):1987. PubMed ID: 1006467
    [No Abstract]   [Full Text] [Related]  

  • 57. Structure and viral interactions of H-2 antigens.
    Cunningham BA; Reske K; Milner RJ; Schrader JW; Ziffer JA
    Birth Defects Orig Artic Ser; 1978; 14(2):203-16. PubMed ID: 76484
    [No Abstract]   [Full Text] [Related]  

  • 58. Inductive requirements for the generation of virus-specific T lymphocytes. III. Production of target cells lysable by poxvirus-specific and allospecific cytotoxic T lymphocytes with membrane fragments bearing viral and H-2 antigens.
    Hapel AJ; Bablanian R; Cole GA
    J Immunol; 1980 Apr; 124(4):1997-2003. PubMed ID: 6154088
    [No Abstract]   [Full Text] [Related]  

  • 59. Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants.
    Dennis JW; Donaghue TP; Carlow DA; Kerbel RS
    Cancer Res; 1981 Oct; 41(10):4010-9. PubMed ID: 6974593
    [No Abstract]   [Full Text] [Related]  

  • 60. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.